Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for St.Shine Optical Co., Ltd. (1565:TWSE), powered by AI.
St.Shine Optical Co., Ltd. is currently trading at $94.20. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for St.Shine Optical Co., Ltd. on Alpha Lenz.
St.Shine Optical Co., Ltd.'s P/E ratio is 10.4.
“St.Shine Optical Co., Ltd. trades at a P/E of 10.4 (undervalued) with modest ROE of 6.9%.”
Ask for details →St.Shine Optical Co., Ltd. is a leading manufacturer within the health technology sector, specializing in the design and production of contact lenses. Established in 1981 and headquartered in New Taipei City, the company creates a diverse range of vision correction products, including daily disposable, frequent replacement, color, toric, and silicone hydrogel lenses. St.Shine Optical offers products under brands such as Ticon, addressing common vision issues like myopia, hyperopia, and astigmatism. Their extensive portfolio employs advanced manufacturing techniques, such as cast-molding and lathe-cutting, to deliver both soft and rigid gas permeable lenses. Serving markets across Asia, Europe, and America, St.Shine Optical also provides consulting services related to optical products. With thousands of employees and a robust distribution network, the company plays a significant role in medical specialties by enhancing visual health and accessibility, particularly through innovative and replacement-focused lens solutions.
“St.Shine Optical Co., Ltd. trades at a P/E of 10.4 (undervalued) with modest ROE of 6.9%.”
Ask for details →St.Shine Optical Co., Ltd. (ticker: 1565) is a company listed on TWSE in the Healthcare sector (Medical Instruments & Supplies). Market cap is $4.7B.
The current price is 94.2 with a P/E ratio of 10.43x and P/B of 0.72x.
ROE is 6.94% and operating margin is 13.92%. Annual revenue is $4.1B.